WE Soda’s Initial Public Offering

Latham & Watkins has advised WE Soda on the offering. WE Soda has announced its potential initial public offering on the London Stock Exchange. The ultimate size of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Permira’s Acquisition of Neuraxpharm

Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here